AIG Hospitals Leverages ZAP-X for Precise Brain Tumor Treatments
AIG Hospitals in Hyderabad has introduced ZAP-X NeuroRadiosurgery, successfully treating around 20 patients monthly with precise non-invasive treatments for brain tumours and related conditions. This multidisciplinary approach offers improved patient outcomes and reduced complications.
Highlights
- •ZAP-X NeuroRadiosurgery at AIG Hospitals treats approximately 20 patients monthly.
- •Cases include benign and malignant brain tumours, trigeminal neuralgia, and more complex skull-base lesions.
- •Precision treatment provides benefits such as faster patient recovery and reduced surgical complications.
- •Multidisciplinary collaboration ensures each patient receives the most suitable care.
Hyderabad-based AIG Hospitals has introduced the cutting-edge ZAP-X NeuroRadiosurgery program, which has been successfully treating approximately 20 patients per month since its inauguration a few months ago. This non-invasive procedure is being used in carefully selected cases where high-precision treatment can significantly benefit patients.
Speaking to credible sources, Dr Subodh Raju, the Director and Head of Neurosurgery at AIG Hospitals, highlighted that ZAP-X is particularly effective for patients with benign and malignant brain tumours, as well as those suffering from various complications such as trigeminal neuralgia. The multidisciplinary approach, involving neurosurgeons, radiation specialists, neuroradiologists, and medical physicists, ensures each patient receives the most suitable treatment.
One notable case involved a patient treated for residual vestibular schwannoma, a tumour located near critical nerves vital for hearing and balance. Traditionally, such lesions are difficult to address due to their proximity to delicate structures, but ZAP-X allowed precise targeting without resorting to an invasive surgical procedure. The patient recovered well and was discharged the same day.
A case of glomus jugulare, a complex skull-base tumour situated near key cranial nerves and blood vessels, further demonstrated the practical benefits of this approach. ZAP-X provided focused treatment without the trauma of open surgery, resulting in fewer complications for the patient.
ZAP-X: A Precise, Non-Invasive Solution
Dr Raju emphasized that while initial results are promising, the long-term outcomes from ZAP-X will take time to fully assess. Nonetheless, the ease of treatment and improved post-procedural comfort have already been noted as significant advantages.
